Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Gastro Intestinal Stromal Tumor × masitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Mastocytosis 4 Recurrence 2 Pruritus 2 Piebaldism 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Mastocytosis, Systemic 2 Gastrointestinal Stromal Tumors 2 Blushing 2 Ovarian Neoplasms 1 Metastatic Castrate Resistant Prostate Cancer 1 Melanoma 1 Gastro-intestinal Stromal Tumours 1 Gastro-Intestinal Stromal Tumour 1 Gastro Intestinal Stromal Tumor 1 Colorectal Neoplasms 1 Colorectal Cancer Metastatic 1

Interventions

masitinib 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01506336 2018-12-11

Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib

AB Science

Phase 2 Completed

Gastro Intestinal Stromal Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡